Sign In
Buy MGNX
$4.69
+0.110 (+2.40%)
At Close: Jun 23, 2026
Why MacroGenics Stock Tumbled Today
06:15pm, Friday, 17'th Mar 2023
An analyst downgraded his recommendation on the cancer-focused biotech. It seemed post-earnings profit-taking also played a role in the selloff.
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
03:00pm, Friday, 17'th Mar 2023 Benzinga
Upgrades
Redburn Partners upgraded the previous rating for FMC Corp (NYSE:FMC) from Neutral to Buy. For the fourth quarter, FMC had an EPS of $2.37, compared to year-ago quarter EPS of $2.16. The stoc
Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
05:56pm, Thursday, 16'th Mar 2023 Benzinga
Gainers
Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficac
Why Shares of MacroGenics Climbed Thursday
04:17pm, Thursday, 16'th Mar 2023 The Motley Fool
The cancer-focused biotech delivered a strong earnings report.
Signet Jewelers, Designer Brands, Academy Sports and Outdoors And Other Big Stocks Moving Higher On Thursday
02:18pm, Thursday, 16'th Mar 2023 Benzinga
U.S. stocks traded lower, with the Dow Jones dropping more than 250 points on Thursday. Here are some big stocks recording gains in today’s session.
PureCycle Technologies, Inc. (NASDAQ: PCT) share
Why Shares of MacroGenics Climbed Thursday
12:17pm, Thursday, 16'th Mar 2023
MacroGenics had its first profitable quarter since Q4 2017. It reported improved revenue and net income in 2022.
MacroGenics (MGNX) Q4 2022 Earnings Call Transcript
03:00am, Thursday, 16'th Mar 2023 The Motley Fool
MGNX earnings call for the period ending December 31, 2022.
MacroGenics (MGNX) Surpasses Q4 Earnings Estimates
09:35pm, Wednesday, 15'th Mar 2023 Zacks Investment Research
MacroGenics (MGNX) delivered earnings and revenue surprises of 170% and 3.05%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
MacroGenics Provides Corporate Update and 2022 Financial Results
08:01pm, Wednesday, 15'th Mar 2023 GlobeNewswire Inc.
ROCKVILLE, Md., March 15, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for
MacroGenics (MGNX) Surpasses Q4 Earnings Estimates
07:05pm, Wednesday, 15'th Mar 2023
MacroGenics (MGNX) delivered earnings and revenue surprises of 170% and 3.05%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Provention (PRVB) Skyrockets 260% on Buyout Offer From Sanofi
04:32pm, Tuesday, 14'th Mar 2023 Zacks Investment Research
Provention Bio (PRVB) to be acquired by pharma-giant Sanofi (SNY) for $2.9 billion. The transaction is likely to close by second-quarter 2023.
Illumina, Seagen And Other Big Stocks Moving Higher On Monday
02:55pm, Monday, 13'th Mar 2023 Benzinga
U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session.
Provention Bio, Inc. (NASDAQ: PRVB) shares
Why Shares of MacroGenics Jumped Thursday
08:59pm, Thursday, 09'th Mar 2023 The Motley Fool
The company made a sale worth as much as $200 million for the royalty rights for its type-1 diabetes therapy.
General Electric, Build-A-Bear Workshop, Asana And Other Big Stocks Moving Higher On Thursday
03:22pm, Thursday, 09'th Mar 2023 Benzinga
U.S. stocks traded higher, with the Dow Jones gaining around 50 points on Thursday. Here are some big stocks recording gains in today’s session.
Solo Brands, Inc. (NYSE: DTC) shares rose 28.1% to
MacroGenics Announces Sale of TZIELD™ Royalty Interest for up to $200 Million
10:36pm, Wednesday, 08'th Mar 2023 GlobeNewswire Inc.
ROCKVILLE, MD, March 08, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based thera
